首页|Identification of conserved regions from 230,163 SARS-CoV-2 genomes and their use in diagnostic PCR primer design
Identification of conserved regions from 230,163 SARS-CoV-2 genomes and their use in diagnostic PCR primer design
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Springer Nature
Abstract Background As the rapidly evolving characteristic of SARS-CoV-2 could result in false negative diagnosis, the use of as much sequence data as possible is key to the identification of conserved viral sequences. However, multiple alignment of massive genome sequences is computationally intensive.Objective To extract conserved sequences from SARS-CoV-2 genomes for the design of diagnostic PCR primers using a bioinformatics approach that can handle massive genomic sequences efficiently.Methods A total of 230,163 full-length viral genomes were retrieved from the NCBI SARS-CoV-2 Resources and GISAID EpiCoV database. This number was reduced to 14.11% following removal of 5′-/3′-untranslated regions and sequence dereplication. Fast, reference-based, multiple sequence alignments identified conserved sequences and specific primer sets were designed against these regions using a conventional tool. Primer sets chosen among the candidates were evaluated by in silico PCR and RT-qPCR.Results Out of 17 conserved sequences (totaling 4.3?kb), two primer sets targeting the nsp2 and ORF3a genes were picked that exhibited?>?99.9% in silico amplification coverage against the original dataset (230,163 genomes) when a 5% mismatch between the primers and target was allowed. In addition, the primer sets successfully detected nine SARS-CoV-2 variant RNA samples (Alpha, Beta, Gamma, Delta, Epsilon, Zeta, Eta, Iota, and Kappa) in experimental RT-qPCR validations.Conclusion In addition to the RdRp, E, N, and S genes that are targeted commonly, our approach can be used to identify novel primer targets in SARS-CoV-2 and should be a priority strategy in the event of novel SARS-CoV-2 variants or other pandemic outbreaks.
SARS-CoV-2Multiple sequence alignmentRT-qPCR
Jeong Haeyoung、Lee Siseok、Ko Junsang、Ko Minsu、Seo Hwi Won
展开 >
Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)
NSTL
Springer Nature
